Virtual Reality to Promote Relaxation Prior to Simulation

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

February 12, 2025

Study Completion Date

February 12, 2025

Conditions
Cancer
Interventions
OTHER

Virtual Reality Program

Study participants will be provided a HTC or Pico VR head-mounted device (HTC Flow, HTC Focus or Pico Neo Pro) which will be fitted for comfort. Patients will remain seated for the entirety of the VR program. The program generally takes about ten minutes to complete but may last up to 11 minutes. The program displays a relaxing environmental setting with narration based in mindfulness meditation principles. Subjects will be prompted to practice breathing exercises designed to relax and reduce anxiety.

Trial Locations (1)

19104

Perelman Center for Advanced Medicine, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT06318338 - Virtual Reality to Promote Relaxation Prior to Simulation | Biotech Hunter | Biotech Hunter